Solutions
Advisory Services
Clinical Development
- Generics Development
- Clinical Operations
- Clinical Data Sciences
- Medical and Safety Services
- RWD & RWE Services
Post Marketing
- Safety Services
- Post marketing Studies
- Regulatory Affairs
Artificial Intelligence is changing the way we think about clinical trials. It’s not a future promise anymore. It’s here, now, and it’s making trials smarter and more efficient. As a US based CRO headquartered in Maryland, we’ve seen first-hand how AI is transforming operations for biotech and pharmaceutical companies ac...
Welcome to "Ask Your Biostatistician," a new expert led series from Navitas Life Sciences. Each edition explores foundational concepts that shape clinical research success, starting with a topic that’s often underestimated but absolutely vital: sample size calculation. Getting It Right from the Start: Strategic Sample Size Selection in Clini...
Ready to Launch your next Registry? So are we! Clinical research organizations (CROs) play a vital role in advancing medical knowledge and improving patient care. With the growing prominence of patient registries in clinical research and real world evidence (RWE) generation, sponsors are recognizing the need for specialized expertise from a patient...
Patient Centricity in Clinical Trials Patient centricity is at the crux of clinical drug trials and clinical medical trials, ensuring that every step of the process prioritizes patient needs, comfort, and engagement. In clinical research, success is no longer defined solely by data and endpoints. It is about the patients who make these trials possi...
As AI in pharmacovigilance gains momentum, organizations are recognizing not just the transformative potential of the technology, but also the complexity of managing its adoption. From signal detection pharmacovigilance to optimizing drug safety pharmacovigilance processes, AI promises accelerated efficiency and proactive benefit-risk management. Y...
Pharmacokinetic (PK) and pharmacodynamic (PD) studies provide critical insights into how a drug is processed by the body (PK) and how it exerts its effects (PD). For pharmaceutical sponsors and biotech companies, especially those working in oncology, understanding and leveraging PK/PD data is crucial from early-stage trials through regulatory submi...
Genetic Insights in Parkinson’s Disease Research Parkinson’s disease (PD), a progressive neurodegenerative disorder, affects more than 10 million people worldwide. With global prevalence expected to double by 2040, the urgency for innovative Parkinson’s disease treatment solutions continues to grow. As the scientific community ...
Enabling Your ESG Goals Through Ours World Environment Day 2025 spotlights how organizations across sectors can meaningfully reduce their environmental footprint and strengthen sustainability reporting. For the life sciences industry—often associated with high resource consumption, extensive logistics, and complex supply chains—sustai...
The United States remains a global leader in the life sciences industry, offering immense opportunities for pharmaceutical and medical device companies worldwide. As one of the most advanced and tightly regulated markets, U.S. requires strict adherence to the U.S. Food and Drug Administration’s (FDA) evolving guidelines. The complex regulato...
International Clinical Trials Day is celebrated on May 20 to honour clinical research advancements. International Clinical Trials Day 2025 is celebrated globally on May 20th to recognize the very first controlled trial by James Lind in 1747 and to honour the contributions of researchers, patients, and sponsors in advancing medical science. This yea...